In last trading session, Cardiff Oncology Inc (NASDAQ:CRDF) saw 1.37 million shares changing hands with its beta currently measuring 1.73. Company’s recent per share price level of $4.70 trading at -$0.08 or -1.67% at ring of the bell on the day assigns it a market valuation of $312.64M. That closing price of CRDF’s stock is at a discount of -36.6% from its 52-week high price of $6.42 and is indicating a premium of 64.89% from its 52-week low price of $1.65.
For Cardiff Oncology Inc (CRDF), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Cardiff Oncology Inc (NASDAQ:CRDF) trade information
Upright in the red during last session for losing -1.67%, in the last five days CRDF remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $4.70 price level, adding 3.49% to its value on the day. Cardiff Oncology Inc’s shares saw a change of 8.29% in year-to-date performance and have moved 8.29% in past 5-day. Cardiff Oncology Inc (NASDAQ:CRDF) showed a performance of 33.52% in past 30-days.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 35.42% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -6.24% while estimates for its earnings growth in next 5 years are of -5.80%.
Cardiff Oncology Inc (NASDAQ:CRDF)’s Major holders
BLACKROCK INC. is the top institutional holder at CRDF for having 2.63 million shares of worth $5.84 million. And as of 2024-06-30, it was holding 5.883 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 2.14 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.7816 of outstanding shares, having a total worth of $4.74 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.25 shares of worth $5.9 million or 2.45% of the total outstanding shares. The later fund manager was in possession of 1.12 shares on Nov 30, 2024 , making its stake of worth around $5.25 million in the company or a holder of 2.18% of company’s stock.
